Summary
Definition
History and exam
Key diagnostic factors
- presence of risk factors
- loss of kidney function
- fever
- rash
- oedema
- decreased urinary volume
Other diagnostic factors
- arthralgia
- uveitis
Risk factors
- use of a triggering medication
- age >65 years
- chronic inflammatory disease
Diagnostic investigations
1st investigations to order
- serum urea and creatinine
- FBC with WBC differential
- urinalysis
- trial of discontinuing triggering medication
- anti-neutrophil cytoplasmic antibody (ANCA)
- anti-nuclear antibody (ANA)
- anti-double stranded DNA (anti-ds DNA)
- complement profile
Investigations to consider
- kidney ultrasound
- kidney biopsy
- kidney gallium scan
- urine cytokines
Treatment algorithm
medication related
chronic inflammatory disease related
Contributors
Authors
Mark A. Perazella, MD, FACP
Professor of Medicine (Nephrology)
Section of Nephrology
Department of Internal Medicine
Yale School of Medicine
New Haven
CT
Disclosures
MAP declares that he has no competing interests. MAP is an author of several references cited in this topic.
Dennis G. Moledina, MBBS, PhD, FASN
Assistant Professor of Medicine (Nephrology)
Department of Internal Medicine (Section of Nephrology)
Clinical and Translational Research Accelerator
Yale School of Medicine
New Haven
CT
Disclosures
DGM (via his employer Yale University) has received a grant from the National Institutes of Health and National Institute of Diabetes & Digestive & Kidney Diseases as an investigator (K23DK117065, R01DK128087, and R01DK126815). He is co-inventorof the pending patent application (number 16/536718), 'System and methods for diagnosing acute interstitial nephritis'. He serves on the board of 'Predict AIN, LLC' and has received honorarium from National Kidney Foundation. DGM is an author of several references cited in this topic.
Acknowledgements
Prof. Mark A. Perazella and Dr Dennis G. Moledina would like to gratefully acknowledge Dr James Marsh, Dr Alice Appel, Dr Gerald Appel, and Dr Kate Shiell, previous contributors to this topic.
Disclosures
JM, AA, GA, and KS declare that they have no competing interests.
Peer reviewers
Irfan Moinuddin, MD
Assistant Professor
Chicago Medical School
Rosalind Franklin University
Lombard
IL
Declarações
IM declares that he has no competing interests.
Catherine Clase, BA, MB, MSC, FRCPC
Associate Professor
Nephrologist
McMaster University
Hamilton
Ontario
Canada
Declarações
CC declares that she has no competing interests.
Robert Mactier, MD, FRCP
Consultant Nephrologist/Lead Clinician
Renal Unit
Glasgow Royal Infirmary
NHS Greater Glasgow and Clyde
Glasgow
UK
Declarações
RM declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Raghavan R, Eknoyan G. Acute interstitial nephritis - a reappraisal and update. Clin Nephrol. 2014 Sep;82(3):149-62.Texto completo Resumo
Praga M, Sevillano A, Auñón P, et al. Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant. 2015 Sep;30(9):1472-9.Texto completo Resumo
Moledina DG, Eadon MT, Calderon F, et al. Development and external validation of a diagnostic model for biopsy-proven acute interstitial nephritis using electronic health record data. Nephrol Dial Transplant. 2022 Oct 19;37(11):2214-22.Texto completo Resumo
Moledina DG, Perazella MA. Drug-induced acute interstitial nephritis. Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2046-9.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Acute glomerulonephritis
- Acute tubular necrosis
- Acute vascular injury
Mais Diagnósticos diferenciaisDiretrizes
- Acute kidney injury: prevention, detection and management
- ACR appropriateness criteria: renal failure
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal